[go: up one dir, main page]

CN102126942A - Method for synthesizing hypericin - Google Patents

Method for synthesizing hypericin Download PDF

Info

Publication number
CN102126942A
CN102126942A CN2010106002464A CN201010600246A CN102126942A CN 102126942 A CN102126942 A CN 102126942A CN 2010106002464 A CN2010106002464 A CN 2010106002464A CN 201010600246 A CN201010600246 A CN 201010600246A CN 102126942 A CN102126942 A CN 102126942A
Authority
CN
China
Prior art keywords
hypericin
reaction
synthetic method
emodin
described step
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN2010106002464A
Other languages
Chinese (zh)
Other versions
CN102126942B (en
Inventor
刘明星
王小利
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wuhan Medical Polytron Technologies Inc
Original Assignee
Hubei University of Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hubei University of Technology filed Critical Hubei University of Technology
Priority to CN 201010600246 priority Critical patent/CN102126942B/en
Publication of CN102126942A publication Critical patent/CN102126942A/en
Application granted granted Critical
Publication of CN102126942B publication Critical patent/CN102126942B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

本发明涉及金丝桃素的合成方法,该方法包括以下步骤:(1)将大黄素和SnCl2·2H2O溶解于冰乙酸中,在升温到100-125℃后加入36-40%的浓盐酸,反应1-3个小时,冷却,得到大黄素蒽酮;(2)将大黄素蒽酮和叔丁醇钾溶解于DMF中,在微波固液相合成/萃取仪中进行反应,反应30-90分钟,冷却,得到原金丝桃素;(3)将原金丝桃素溶解于丙酮后,卤素灯照射15-24小时,浓缩,沉淀,得到金丝桃素。该方法具有操作简单、成本低、污染少、收率和纯度高等优点。The present invention relates to a synthetic method of hypericin, which comprises the following steps: (1) dissolving emodin and SnCl 2 ·2H 2 O in glacial acetic acid, adding 36-40% of Concentrated hydrochloric acid, reacted for 1-3 hours, cooled to obtain emodin anthrone; (2) dissolve emodin anthrone and potassium tert-butoxide in DMF, react in a microwave solid-liquid phase synthesis/extractor, and react 30-90 minutes, cooling to obtain protohypericin; (3) dissolving protohypericin in acetone, irradiating with halogen lamp for 15-24 hours, concentrating and precipitating to obtain hypericin. The method has the advantages of simple operation, low cost, less pollution, high yield and purity.

Description

金丝桃素合成方法Synthetic method of hypericin

技术领域technical field

本发明属于药物合成领域,涉及金丝桃素的合成方法。The invention belongs to the field of medicine synthesis and relates to a synthesis method of hypericin.

背景技术Background technique

金丝桃素(hypericin),即4,4,5,5,7,7-六羟基-2,2-二甲基-中位-萘并二蒽酮,为藤黄科植物贯叶连翘的带花全草经加工提取而成,对流感等病毒作用针对性强,效果显著。金丝桃素具有抗病毒、抗抑郁、镇静、抗菌消炎、创伤收敛等多种药理作用,能抑制DNA、RNA病毒,对肿瘤细胞也有一定的抑制作用。金丝桃素的多种药理作用,使其市场需求量与日俱增。由于金丝桃素在贯叶连翘全草中的含量仅有万分之四左右,目前,国内外从贯叶连翘中提取的金丝桃素在其提取物中的含量不超过1%,即便是改善提取工艺,提取、分离出来的金丝桃素的含量也不是很高,而且还会破坏大量的天然植被或占用大量耕地。为了扩大金丝桃素的药物来源,提高金丝桃素的含量,只有通过有效的化学合成方法实现这一目标。Hypericin, that is, 4,4,5,5,7,7-hexahydroxy-2,2-dimethyl-middle-naphthodianthrone, is the belt of Hypericum perforatum of Garciniaceae The whole flower is processed and extracted, and it has a highly targeted and effective effect on viruses such as influenza. Hypericin has various pharmacological effects such as antiviral, antidepressant, sedative, antibacterial and anti-inflammatory, and wound astringent. It can inhibit DNA and RNA viruses, and also has a certain inhibitory effect on tumor cells. The multiple pharmacological effects of hypericin make its market demand increasing day by day. Since the content of hypericin in the whole plant of Hypericum perforatum is only about 4/10,000, at present, the content of hypericin extracted from Hypericum perforatum in its extracts at home and abroad does not exceed 1%. Extraction process, the content of hypericin extracted and separated is not very high, and it will destroy a large amount of natural vegetation or occupy a large amount of cultivated land. In order to expand the drug source of hypericin and increase the content of hypericin, this goal can only be achieved through effective chemical synthesis methods.

中国专利申请CN1827574A公开了一种金丝桃素及其衍生物的化学合成方法。该方法包括以下步骤:1)将1,3,8-三羟基-6-甲基蒽醌溶解于分析纯冰乙酸中,然后加入含有SnCl2·2H2O的36-40%浓盐酸,在不高于125℃下反应1-4小时,冷却,得到1,3,8-三羟基-6-甲基蒽酮;2)将1,3,8-三羟基-6-甲基蒽酮与吡啶,哌啶,氮氧吡啶和FeSO4·7H2O在100-130℃下避光反应0.5-3小时,再将反应产物溶解于丙酮,用卤素灯照射12-24小时,浓缩,用正己烷溶解,过滤沉淀,得到金丝桃素。该文献公开的合成路线属于传统的合成反应过程,具有反应时间长,反应成分复杂,环境污染大,操作麻烦和产品难纯化等缺点。Chinese patent application CN1827574A discloses a chemical synthesis method of hypericin and its derivatives. The method comprises the following steps: 1) dissolving 1,3,8-trihydroxy-6-methylanthraquinone in analytically pure glacial acetic acid, then adding 36-40% concentrated hydrochloric acid containing SnCl 2 ·2H 2 O, in React at no higher than 125°C for 1-4 hours, cool to obtain 1,3,8-trihydroxy-6-methylanthrone; 2) combine 1,3,8-trihydroxy-6-methylanthrone with Pyridine, piperidine, nitridine and FeSO 4 7H 2 O reacted at 100-130°C in the dark for 0.5-3 hours, then dissolved the reaction product in acetone, irradiated with a halogen lamp for 12-24 hours, concentrated, and washed with n-hexane The alkane was dissolved, and the precipitate was filtered to obtain hypericin. The synthetic route disclosed in this document belongs to the traditional synthetic reaction process, which has the disadvantages of long reaction time, complex reaction components, large environmental pollution, cumbersome operation and difficult purification of products.

发明内容Contents of the invention

鉴于合成金丝桃素的现有技术存在的缺点,本发明的目的是提供一种成本较低,相对收率和产率高,污染环境少的金丝桃素合成方法。In view of the shortcomings of the prior art of synthesizing hypericin, the purpose of the present invention is to provide a hypericin synthesis method with low cost, high relative yield and yield, and less environmental pollution.

为了实现本发明的目的,发明人通过大量试验改进反应条件和方法,探索出了一种有效的合成金丝桃素的方法,具体技术方案如下:In order to realize the purpose of the present invention, the contriver improves reaction conditions and method through a large number of tests, has explored a kind of method of effective synthetic hypericin, and concrete technical scheme is as follows:

一种金丝桃素合成方法,包括步骤如下步骤:A kind of synthetic method of hypericin, comprises the following steps:

(1)将大黄素转化为大黄素蒽酮(1) Convert emodin into emodin anthrone

Figure BDA0000039924900000021
Figure BDA0000039924900000021

(2)将大黄素蒽酮转化为原金丝桃素(2) Convert emodin anthrone into protohypericin

Figure BDA0000039924900000022
Figure BDA0000039924900000022

(3)将原金丝桃素转化为金丝桃素(3) Convert the original hypericin into hypericin

Figure BDA0000039924900000023
Figure BDA0000039924900000023

所述步骤(2)是在微波的条件下,以叔丁醇钾作为催化剂进行大黄素蒽酮催化缩合反应。The step (2) is to carry out the catalyzed condensation reaction of emodin anthrone with potassium tert-butoxide as a catalyst under microwave conditions.

上述的金丝桃素合成方法,其中优选步骤(2)为:将大黄素蒽酮和叔丁醇钾溶解于DMF中,在微波固液相合成/萃取仪中进行反应,冷却,分离得到原金丝桃素,其中大黄素蒽酮与叔丁醇钾的摩尔比为3-5∶0.5-0.7。进一步优选步骤(2)为:将大黄素蒽酮和叔丁醇钾溶解于DMF中,在微波固液相合成/萃取仪中进行反应,冷却,分离得到原金丝桃素,其中大黄素蒽酮与叔丁醇钾的摩尔比为3-5∶0.5-0.7;且大黄素蒽酮催化缩合反应以Ar2保护,微波反应功率保持在250-550W,反应温度为130-150℃,反应时间为30-90分钟。The above-mentioned synthetic method of hypericin, wherein the preferred step (2) is: dissolving emodin anthrone and potassium tert-butoxide in DMF, reacting in a microwave solid-liquid phase synthesis/extractor, cooling, and separating to obtain the original Hypericin, wherein the molar ratio of emodin anthrone to potassium tert-butoxide is 3-5:0.5-0.7. Further preferred step (2) is: dissolving emodin anthrone and potassium tert-butoxide in DMF, reacting in a microwave solid-liquid phase synthesis/extraction apparatus, cooling, and separating to obtain protohypericin, wherein emodin anthracene The molar ratio of ketone to potassium tert-butoxide is 3-5:0.5-0.7; and the catalyzed condensation reaction of emodin anthrone is protected by Ar 2 , the microwave reaction power is kept at 250-550W, the reaction temperature is 130-150°C, and the reaction time for 30-90 minutes.

上述的金丝桃素合成方法,所述步骤(2)催化缩合反应获得的产物需经硅胶柱层析纯化,洗脱液是体积比为4∶8∶2-0.3的石油醚∶乙酸乙酯∶甲醇。In the above-mentioned synthetic method of hypericin, the product obtained by the catalytic condensation reaction in the step (2) needs to be purified by silica gel column chromatography, and the eluent is petroleum ether with a volume ratio of 4:8:2-0.3: ethyl acetate : Methanol.

上述任一一种金丝桃素合成方法,所述步骤(1)为:将大黄素和SnCl2·2H2O溶解于冰乙酸中,升温至100-125℃,然后分批加入浓盐酸,保持反应温度100-125℃,反应1-3个小时,冷却,分离得到大黄素蒽酮;其中大黄素与SnCl2·2H2O的摩尔比为1∶3.5-5,冰乙酸与浓盐酸体积比为5∶1-3。进一步优选步骤(2)为:将大黄素和SnCl2·2H2O溶解于冰乙酸中,升温至100-125℃,然后分批加入浓盐酸,保持反应温度100-125℃,反应1-3个小时,冷却,分离得到大黄素蒽酮;其中大黄素与SnCl2·2H2O的摩尔比为1∶1.5-3.5,冰乙酸与浓盐酸体积比为5∶1-3;且整个反应过程中以Ar2保护,在反应温度达到100-125℃,且出现回流现象时分批缓慢加入浓盐酸。In any one of the hypericin synthesis methods above, the step (1) is: dissolving emodin and SnCl 2 ·2H 2 O in glacial acetic acid, raising the temperature to 100-125°C, and then adding concentrated hydrochloric acid in batches, Keep the reaction temperature at 100-125°C, react for 1-3 hours, cool, and separate emodin anthrone; wherein the molar ratio of emodin to SnCl 2 2H 2 O is 1:3.5-5, and the volume of glacial acetic acid and concentrated hydrochloric acid The ratio is 5:1-3. A further preferred step (2) is: dissolve emodin and SnCl 2 ·2H 2 O in glacial acetic acid, raise the temperature to 100-125°C, then add concentrated hydrochloric acid in batches, keep the reaction temperature at 100-125°C, and react 1-3 Hours, cooled, and separated to obtain emodin anthrone; wherein the molar ratio of emodin to SnCl 2 2H 2 O was 1:1.5-3.5, and the volume ratio of glacial acetic acid to concentrated hydrochloric acid was 5:1-3; and the whole reaction process Protected by Ar 2 in the middle, when the reaction temperature reaches 100-125°C and reflux occurs, concentrated hydrochloric acid is slowly added in batches.

上述任一一种金丝桃素合成方法,所述步骤(3)为:将原金丝桃素溶解于丙酮后,卤素灯照射15-24小时,浓缩,得到金丝桃素;其中所述原金丝桃素和丙酮摩尔比为0.5-0.7∶3-10。进一步优选步骤(2)为:将原金丝桃素溶解于丙酮后,Ar2保护,并且将Ar2通入液面以下,卤素灯照射15-24小时,浓缩,得到金丝桃素;其中所述原金丝桃素和丙酮摩尔比为0.5-0.7∶3-10。Any one of the above hypericin synthesis methods, the step (3) is: after dissolving the original hypericin in acetone, irradiating with a halogen lamp for 15-24 hours, and concentrating to obtain hypericin; wherein the The molar ratio of protohypericin and acetone is 0.5-0.7: 3-10. Further preferred step (2) is: after the original hypericin is dissolved in acetone, Ar 2 is protected, and Ar 2 is introduced below the liquid level, irradiated by a halogen lamp for 15-24 hours, and concentrated to obtain hypericin; wherein The molar ratio of protohypericin to acetone is 0.5-0.7:3-10.

与现有技术相比,本发明的金丝桃素合成方法具有如下有益的技术效果:发明人创造性地以叔丁醇钾为强碱催化剂催化大黄素蒽酮的缩合反应,使得制备金丝桃素的操作简单,制备成本较低,相对收率和纯度更高,环境污染少,取得到了较为理想的效果。Compared with the prior art, the hypericin synthesis method of the present invention has the following beneficial technical effects: the inventor creatively uses potassium tert-butoxide as a strong base catalyst to catalyze the condensation reaction of emodin anthrone, making the preparation of hypericin The operation of the element is simple, the preparation cost is low, the relative yield and purity are higher, the environmental pollution is less, and a relatively ideal effect has been obtained.

具体实施方式Detailed ways

以下是本发明的具体实施例,对本发明的技术方案做进一步作描述,但是本发明的保护范围并不限于这些实施例。凡是不背离本发明构思的改变或等同替代均包括在本发明的保护范围之内。The following are specific examples of the present invention, and further describe the technical solution of the present invention, but the protection scope of the present invention is not limited to these examples. All changes or equivalent substitutions that do not depart from the concept of the present invention are included in the protection scope of the present invention.

下述实施例中所用方法如无特别说明均为常规方法。The methods used in the following examples are conventional methods unless otherwise specified.

现用本发明的方法人工合成金丝桃素,具体实例包括以下步骤:Now use the method artificial synthesis hypericin of the present invention, concrete example comprises the following steps:

(1)将大黄素转化为大黄素蒽酮(1) Convert emodin into emodin anthrone

取大黄素2g(7.4mmol),加入冰乙酸120mL中,Ar2保护,搅拌下加入SnCl2·2H2O2.8g(12.4mmol),将混合物开始加热,反应温度达到115℃,开始出现回流现象。在110℃左右,逐滴加浓盐酸48mL,加毕,回流反应2h(TLC跟踪)。放置冷却后,用布氏漏斗过滤,残基用去离子水洗至中性,真空干燥后称重得到大黄素蒽酮1.766mg,产率93%。Take 2 g (7.4 mmol) of emodin, add it to 120 mL of glacial acetic acid, protect it with Ar 2 , add SnCl 2 2H 2 O 2.8 g (12.4 mmol) under stirring, start heating the mixture, the reaction temperature reaches 115 °C, and reflux begins to appear . At about 110°C, 48 mL of concentrated hydrochloric acid was added dropwise, and after the addition was complete, the reaction was refluxed for 2 h (TLC tracking). After standing to cool, filter with a Buchner funnel, wash the residue with deionized water until neutral, vacuum dry and weigh to obtain 1.766 mg of emodin anthrone with a yield of 93%.

TLC跟踪反应历程时,每隔半个小时,吸取20μL反应液,加入适量无水乙醇令其完全溶解,制备样品溶液。然后精确称取大黄素蒽酮1mg加无水乙醇溶解,用移液器吸出,移至25mL容量瓶中,用无水乙醇洗涤多次,加无水乙醇定溶至25mL,制备原料溶液。将制备好的反应液与大黄素蒽酮乙醇溶液点于薄层层析板上,选用氯仿∶甲醇的体积比为3∶1作为展开剂,观察反应体系中反应物黄色斑点与生成物荧光斑点的变化,以此为指标来判断反应进行的程度。When tracking the reaction process by TLC, draw 20 μL of the reaction solution every half hour, add an appropriate amount of absolute ethanol to dissolve it completely, and prepare a sample solution. Then accurately weigh 1mg of emodin anthrone and add absolute ethanol to dissolve it, suck it out with a pipette, transfer it to a 25mL volumetric flask, wash with absolute ethanol several times, add absolute ethanol to dilute to 25mL, and prepare a raw material solution. Spot the prepared reaction solution and emodin anthrone ethanol solution on a thin-layer chromatography plate, choose chloroform:methanol with a volume ratio of 3:1 as the developer, and observe the yellow spots of the reactants and the fluorescent spots of the products in the reaction system The change is used as an indicator to judge the extent of the reaction.

(2)将大黄素蒽酮转化为原金丝桃素(2) Convert emodin anthrone into protohypericin

取大黄素蒽酮1.024g(4mmol)和0.062g(0.55mmol)叔丁醇钾溶解于40mL DMF(N,N-二甲基甲酰胺)中,磁力搅拌,在微波固液相合成/萃取仪中进行反应,反应之前通入Ar2,排尽反应瓶内的空气。设置反应温度为145℃,反应功率为450W,反应时间为40mim,开始反应。反应完后待其冷却到室温,加入去离子水。加入2mol盐酸,调节溶液pH值为2,用布氏漏斗过滤,沉淀用冷水洗至中性,真空干燥。经硅胶柱层析柱上洗脱,洗脱液(石油醚∶乙酸乙酯∶甲醇=4∶8∶0.9),得到原金丝桃素0.544mg,收率53.9%Get 1.024g (4mmol) of emodin anthrone and 0.062g (0.55mmol) of potassium tert-butoxide dissolved in 40mL of DMF (N,N-dimethylformamide), magnetic stirring, in the microwave solid-liquid phase synthesis/extraction apparatus The reaction was carried out in , and Ar 2 was passed through before the reaction, and the air in the reaction bottle was exhausted. Set the reaction temperature to 145°C, the reaction power to 450W, and the reaction time to 40mim to start the reaction. After the reaction, it was cooled to room temperature, and deionized water was added. Add 2 mol hydrochloric acid to adjust the pH value of the solution to 2, filter it with a Buchner funnel, wash the precipitate with cold water until neutral, and dry it in vacuum. After elution on a silica gel column chromatography column, the eluent (petroleum ether: ethyl acetate: methanol = 4:8:0.9) obtained 0.544 mg of prohypericin, with a yield of 53.9%

(3)将原金丝桃素转化为金丝桃素(3) Convert the original hypericin into hypericin

将原金丝桃素170mg(0.33mmol)溶解于500mL丙酮后,Ar2保护,在500瓦的卤素灯下照射24小时。反应完成后,旋转蒸发溶剂至5mL。真空干燥后称重得到产物。将上述所得产物经硅胶柱层析柱上洗脱,洗脱液(石油醚∶乙酸乙酯∶甲醇=4∶8∶0.5),得到金丝桃素150mg,收率95%。(含量为≥98.5%)。Protohypericin 170 mg (0.33 mmol) was dissolved in 500 mL of acetone, protected by Ar 2 and irradiated under a 500-watt halogen lamp for 24 hours. After the reaction was complete, the solvent was rotovapped to 5 mL. After vacuum drying, the product was weighed. The product obtained above was eluted on a silica gel column chromatography, and the eluent (petroleum ether: ethyl acetate: methanol = 4:8:0.5) was used to obtain 150 mg of hypericin with a yield of 95%. (content is ≥ 98.5%).

Claims (8)

1. hypericin synthetic method, comprise that step (1) is converted into emodin anthrone with Schuttgelb, (2) emodin anthrone is converted into former hypericin, (3) former hypericin is converted into hypericin, it is characterized in that: described step (2) is under the condition of microwave, carries out the reaction of emodin anthrone catalyzing and condensing with potassium tert.-butoxide as catalyzer.
2. hypericin synthetic method as claimed in claim 1, it is characterized in that: described step (2) is that emodin anthrone and potassium tert.-butoxide are dissolved among the DMF, be combined at the microwave solid-liquid/react in the abstraction instrument, cooling, separate obtaining former hypericin, wherein the mol ratio of emodin anthrone and potassium tert.-butoxide is 3-5: 0.5-0.7.
3. hypericin synthetic method as claimed in claim 2 is characterized in that: the reaction of emodin anthrone catalyzing and condensing is with Ar in the described step (2) 2Protection, microwave reaction power remains on 250-550W, and temperature of reaction is 130-150 ℃, and the reaction times is 30-90 minute.
4. hypericin synthetic method as claimed in claim 3 is characterized in that: the product that the reaction of described step (2) catalyzing and condensing obtains is through purification by silica gel column chromatography, and elutriant is that volume ratio is 4: 8: the sherwood oil of 2-0.3: ethyl acetate: methyl alcohol.
5. as the arbitrary described hypericin synthetic method of claim 1-4, it is characterized in that: described step (1) is with Schuttgelb and SnCl 22H 2O is dissolved in the glacial acetic acid, is warming up to 100-125 ℃, adds concentrated hydrochloric acid then in batches, keeps 100-125 ℃ of temperature of reaction, reaction 1-3 hour, and cooling separates obtaining emodin anthrone; Wherein Schuttgelb and SnCl 22H 2The mol ratio of O is 1: 3.5-5, glacial acetic acid and concentrated hydrochloric acid volume ratio are 5: 1-3.
6. hypericin synthetic method as claimed in claim 5 is characterized in that: in the reaction process of described step (1) with Ar 2Protection reaches 100-125 ℃ in temperature of reaction, and slowly adds concentrated hydrochloric acid when backflow phenomenon occurring in batches.
7. as the arbitrary described hypericin synthetic method of claim 1-4, it is characterized in that: described step (3) is after former hypericin is dissolved in acetone, and halogen lamp irradiation 15-24 hour concentrates, and obtains hypericin; Wherein said former hypericin and acetone mol ratio are 0.5-0.7: 3-10.
8. hypericin synthetic method as claimed in claim 7 is characterized in that: after former hypericin is dissolved in acetone, and Ar 2Protection, and with Ar 2Below the feeding liquid level.
CN 201010600246 2010-12-22 2010-12-22 Synthetic method of hypericin Expired - Fee Related CN102126942B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 201010600246 CN102126942B (en) 2010-12-22 2010-12-22 Synthetic method of hypericin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 201010600246 CN102126942B (en) 2010-12-22 2010-12-22 Synthetic method of hypericin

Publications (2)

Publication Number Publication Date
CN102126942A true CN102126942A (en) 2011-07-20
CN102126942B CN102126942B (en) 2013-10-23

Family

ID=44265263

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 201010600246 Expired - Fee Related CN102126942B (en) 2010-12-22 2010-12-22 Synthetic method of hypericin

Country Status (1)

Country Link
CN (1) CN102126942B (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103274920A (en) * 2013-06-14 2013-09-04 西北农林科技大学 Efficient hypericin synthesizing method initiated by monochromatic light
CN108084065A (en) * 2017-11-21 2018-05-29 中国农业科学院兰州畜牧与兽药研究所 A kind of hypericin derivative and its preparation method and application
CN108863741A (en) * 2017-05-11 2018-11-23 上海凯伟化工科技有限公司 A kind of synthetic method of hypericin
CN111138262A (en) * 2020-01-13 2020-05-12 成都金石缘科技有限公司 Hypericin synthesis method

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1827574A (en) * 2006-04-19 2006-09-06 中国农业科学院兰州畜牧与兽药研究所 Chemical synthesis method of hypericin and its derivatives

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1827574A (en) * 2006-04-19 2006-09-06 中国农业科学院兰州畜牧与兽药研究所 Chemical synthesis method of hypericin and its derivatives

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
STEFAN AIGNER ET AL.: "A microwave-assisted synthesis of phenanthroperylene quinones as exemplified with hypericin", 《MONATSHEFTE FÜR CHEMIE》 *
汤媛 等: "金丝桃素的合成工艺改进", 《合成化学》 *
汤媛 等: "金丝桃素研究进展", 《医药导报》 *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103274920A (en) * 2013-06-14 2013-09-04 西北农林科技大学 Efficient hypericin synthesizing method initiated by monochromatic light
CN103274920B (en) * 2013-06-14 2014-12-17 西北农林科技大学 Efficient hypericin synthesizing method initiated by monochromatic light
CN108863741A (en) * 2017-05-11 2018-11-23 上海凯伟化工科技有限公司 A kind of synthetic method of hypericin
CN108084065A (en) * 2017-11-21 2018-05-29 中国农业科学院兰州畜牧与兽药研究所 A kind of hypericin derivative and its preparation method and application
CN108084065B (en) * 2017-11-21 2020-06-16 中国农业科学院兰州畜牧与兽药研究所 A kind of hypericin derivative and its preparation method and application
CN111138262A (en) * 2020-01-13 2020-05-12 成都金石缘科技有限公司 Hypericin synthesis method

Also Published As

Publication number Publication date
CN102126942B (en) 2013-10-23

Similar Documents

Publication Publication Date Title
CN102126942B (en) Synthetic method of hypericin
CN106046093A (en) Synthesizing method of lithocholic acid
CN110128382B (en) Preparation method and application of phellinus igniarius seed extract
CN102180782B (en) Method for synthesizing hypericin
CN105237503A (en) Method for preparing baicalein
CN105218499B (en) A kind of method for preparing scutellarin aglycon
CN108358913A (en) A kind of green synthesis process of rotundine sulfate
CN101519393A (en) Novel method for preparing Scopoletin
CN101348411B (en) Preparation of 2-alkyl anthracene derivative
CN106008499B (en) A kind of method for preparing CDK46 kinase inhibitors Pa Boxini
CN111362943A (en) Preparation method of entecavir intermediate N4
CN106946831B (en) A kind of 2-aryl-3-(difluoroalkyl) flavonoids and preparation method thereof
CN101928252B (en) Preparation method of 3-methyl-2-ethanol based quinoxaline
US11208419B2 (en) Phenylbenzofuran compound, preparation method therefor, composition containing the same and medical application thereof
CN100564340C (en) (2E, 4E)-preparation method of 2-methyl-6-oxo-2
CN109651121B (en) Synthetic method of Robtein
CN109694311B (en) A kind of synthetic method of isoliquiritigenin
CN106543208A (en) Copper chloride (II) chelate and its synthetic method and application with 1 pyridine β carbolines as part
CN106554362A (en) A kind of copper chloride (II) chelate and its synthetic method and application with 1 pyridine β carbolines as part
CN111732501A (en) A kind of method for preparing guaiazulene aldehyde dimer in two steps
CN115181112B (en) Synthesis of 3,4-diketone Derivatives of 6-Bromocyclo-Epimedium Chroman and Its Antitumor Application
CN101580499B (en) Reaction system and method for generating flavanone by cyclization of 2'-hydroxy chalcone
CN112457243B (en) Synthesis method of 7-bromo-5-methoxyquinoline
CN115073485B (en) 3-aryl-7, 8-pyranocoumarin derivative, and preparation method and application thereof
CN106518825B (en) A kind of chemoselective monomethylation method of coumarin catechol compound

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: HUBEI SHINREZING PHARMACEUTICAL CO., LTD.

Free format text: FORMER OWNER: HUBEI INDUSTRY UNIVERSITY

Effective date: 20140519

C41 Transfer of patent application or patent right or utility model
COR Change of bibliographic data

Free format text: CORRECT: ADDRESS; FROM: 430068 WUHAN, HUBEI PROVINCE TO: 430079 WUHAN, HUBEI PROVINCE

TR01 Transfer of patent right

Effective date of registration: 20140519

Address after: 430079 No. 666, hi tech Avenue, East Lake hi tech Development Zone, Hubei, Wuhan

Patentee after: Hubei Shinrezing Pharmaceutical Co., Ltd.

Address before: 430068 Wuchang, Hubei Province, South Lake, Li Jia Dun special No. 1

Patentee before: Hubei Industry University

ASS Succession or assignment of patent right

Owner name: LIU MINGXING

Free format text: FORMER OWNER: HUBEI SHINREZING PHARMACEUTICAL CO., LTD.

Effective date: 20140529

C41 Transfer of patent application or patent right or utility model
COR Change of bibliographic data

Free format text: CORRECT: ADDRESS; FROM: 430079 WUHAN, HUBEI PROVINCE TO: 430068 WUHAN, HUBEI PROVINCE

TR01 Transfer of patent right

Effective date of registration: 20140529

Address after: 430068 College of food and pharmaceutical engineering, Ministry of light industry, Hubei University of Technology, Hongshan District, Wuhan, Hubei

Patentee after: Liu Mingxing

Address before: 430079 No. 666, hi tech Avenue, East Lake hi tech Development Zone, Hubei, Wuhan

Patentee before: Hubei Shinrezing Pharmaceutical Co., Ltd.

ASS Succession or assignment of patent right

Owner name: WUHAN MAIDESEN MEDICAL TECHNOLOGY CO., LTD.

Free format text: FORMER OWNER: LIU MINGXING

Effective date: 20150217

C41 Transfer of patent application or patent right or utility model
COR Change of bibliographic data

Free format text: CORRECT: ADDRESS; FROM: 430068 WUHAN, HUBEI PROVINCE TO: 430079 WUHAN, HUBEI PROVINCE

TR01 Transfer of patent right

Effective date of registration: 20150217

Address after: 430079 No. 666, hi tech Avenue, East Lake hi tech Development Zone, Hubei, Wuhan

Patentee after: Wuhan Maidesen Medical Technology Co.,Ltd.

Address before: 430068 College of food and pharmaceutical engineering, Ministry of light industry, Hubei University of Technology, Hongshan District, Wuhan, Hubei

Patentee before: Liu Mingxing

TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20200121

Address after: 430000, building, B, C and D District, Wuhan hi tech Avenue, East Lake Development Zone, Wuhan, Hubei Province, B1

Patentee after: Wuhan medical Polytron Technologies Inc

Address before: 430079 No. 666, hi tech Avenue, East Lake hi tech Development Zone, Hubei, Wuhan

Patentee before: Wuhan Maidesen Medical Technology Co.,Ltd.

CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20131023

Termination date: 20201222

CF01 Termination of patent right due to non-payment of annual fee